Skip to Content
Merck
All Photos(1)

Documents

Y0000165

Tribenoside

European Pharmacopoeia (EP) Reference Standard

Synonym(s):

Ethyl 3,5,6-tri-O-benzyl-D-glucofuranoside

Sign Into View Organizational & Contract Pricing
All Photos(1)

About This Item

Empirical Formula (Hill Notation):
C29H34O6
CAS Number:
10310-32-4
Molecular Weight:
478.58
EC Number:
233-687-2
UNSPSC Code:
41116107
NACRES:
NA.24

grade

pharmaceutical primary standard

API family

tribenoside

manufacturer/tradename

EDQM

application(s)

pharmaceutical (small molecule)

format

neat

shipped in

wet ice

storage temp.

−20°C

InChI

1S/C29H34O6/c1-2-32-29-26(30)28(34-20-24-16-10-5-11-17-24)27(35-29)25(33-19-23-14-8-4-9-15-23)21-31-18-22-12-6-3-7-13-22/h3-17,25-30H,2,18-21H2,1H3/t25?,26-,27-,28-,29?/m1/s1

InChI key

ULLNJSBQMBKOJH-NUZMXOBKSA-N

Related Categories

General description

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the Issuing Pharmacopoeia. For further information and support please go to the website of the issuing Pharmacopoeia.

Application

Tribenoside EP Reference standard, intended for use in laboratory tests only as specifically prescribed in the European Pharmacopoeia.

Packaging

The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity, please visit the EDQM reference substance catalogue.

Other Notes

Sales restrictions may apply.

Storage Class Code

11 - Combustible Solids

Flash Point(F)

Not applicable

Flash Point(C)

Not applicable

Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number

Sorry, we don't have COAs for this product available online at this time.

If you need assistance, please contact Customer Support.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

D A Kalbhen
Zeitschrift fur Rheumatologie, 42(4), 187-194 (1983-07-01)
Due to their pharmacological properties most antiphlogistic/antirheumatic drugs are successfully used for treatment of inflammatory rheumatic diseases, but they are not able to counteract cartilage degeneration in osteoarthrosis. For specific therapy of osteoarthrosis only those drugs are suitable, which are
[Centella asiatica extract in venous pathology of the lower limbs and its evaluation as compared with tribenoside].
F Marastoni et al.
Minerva cardioangiologica, 30(4), 201-207 (1982-04-01)
Yamato Kikkawa et al.
Biological & pharmaceutical bulletin, 33(2), 307-310 (2010-02-02)
Tribenoside has been used clinically for hemorrhoidal disease associated with coagulation, inflammation, and wounds. However, the pharmacological mechanism of tribenoside activity has never been clear. In this study we examined whether tribenoside affected expression and deposition of laminins that are
G M Iakovlev et al.
Vestnik khirurgii imeni I. I. Grekova, 126(2), 71-76 (1981-02-01)
The investigation of the peripheral circulation by using the all-purpose occlusion rheoplethysmography enables the reaction of rising the venous tone in response to the action exerted by the tissue ischemia products to be quantitatively estimated along with a one-time determination
[Glyvenol electrophoresis in the correction of microcirculation disorders in parodontitis].
Iu V Zil'berman
Voprosy kurortologii, fizioterapii, i lechebnoi fizicheskoi kultury, (5)(5), 54-55 (1983-09-01)
View All Related Papers

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service